Related Experiment Video
Updated: Jan 14, 2026
07:13
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
18.5K
Adverse Childhood Experiences and Antidepressant Therapy: A Systematic Review
Dixie Meyer1, Ali Abid2, Awais Paracha3
1Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Missouri Medicine
|October 24, 2025
Summary
Adverse childhood experiences (ACEs) are linked to depression and impact antidepressant (ADM) effectiveness. Understanding ACEs is crucial for personalized depression treatment and monitoring suicide risk in survivors.
Area of Science:
- Psychiatry
- Neuroscience
- Public Health
Background:
- Adverse childhood experiences (ACEs) are associated with increased depression risk.
- The impact of ACEs on antidepressant (ADM) treatment outcomes requires further investigation.
- Limited cumulative research exists on specific ACEs and their conjunction with ADM outcomes.
Purpose of the Study:
- To review and synthesize existing research on the relationship between ACEs and ADM treatment.
- To examine how ACEs influence the efficacy and outcomes of antidepressant medications.
- To identify patterns and potential moderators in the ACEs-ADM relationship.
Main Methods:
- Systematic literature search of PsychInfo and PubMed/MEDLINE databases (2010-2025).
- Inclusion of 26 peer-reviewed publications that concurrently examined ACEs and ADM.
- Analysis of findings related to ACEs, ADM use, efficacy, and patient outcomes.
Main Results:
- ACEs correlate with higher ADM use, altered DNA methylation affecting ADM efficacy, and increased suicide risk during ADM treatment.
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) show promise for ACE survivors.
- Multiple ACEs and child abuse can reduce ADM effectiveness, potentially moderated by genetic factors and age of exposure.
Conclusions:
- ACE history is a significant factor influencing depression and response to ADMs.
- Healthcare providers should screen for ACEs and consider tailored treatment strategies, including careful monitoring for persistent symptoms and suicide risk.
- Further research with larger sample sizes and controlled comparisons is needed to clarify the complex ACEs-ADM interactions.
Related Concept Videos
01:25Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
01:23Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
01:30Attention-Deficit/Hyperactivity Disorder
743
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
743
01:30Electroconvulsive Therapy
864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
01:27Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437